republic-os/legislation/us/states/la/2025/sb-243.md

type, title, description, jurisdiction, legislature, session, identifier, citation, classification, subjects, status, primary_sponsors, version_count, action_count, vote_count, first_action, last_action, source, source_identifier, source_url, source_hash, vintage, source_snapshot, retrieved_at, confidence, tags

type	title	description	jurisdiction	legislature	session	identifier	citation	classification	subjects	status	primary_sponsors	version_count	action_count	vote_count	first_action	last_action	source	source_identifier	source_url	source_hash	vintage	source_snapshot	retrieved_at	confidence	tags
Bill	TAX EXEMPTIONS: Provides relative to the sales and use tax exemption for the sale of certain prescription drugs. (gov sig) (EN SEE FISC NOTE LF RV See Note)	TAX EXEMPTIONS: Provides relative to the sales and use tax exemption for the sale of certain prescription drugs. (gov sig) (EN SEE FISC NOTE LF RV See Note)	us/states/la	Louisiana Legislature	2025	SB 243	Louisiana SB 243 (2025)	bill		enacted	Mike Reese	6	18	2	2025-04-23	2025-06-11	openstates	ocd-bill/b249549d-a543-4fd9-9ef9-0ae12e765364	https://www.legis.la.gov/Legis/BillInfo.aspx?i=248942	8f62d279134bb82fee284eae4d5b532d5e28f31668f5dcb05ecc19a8cbbcea8d	2026-07-01	https://data.openstates.org/daily/2026-07-01/public.pgdump	2026-07-06	reported	legislation bill us-la

Louisiana SB 243 (2025) — TAX EXEMPTIONS: Provides relative to the sales and use tax exemption for the sale of certain prescription drugs. (gov sig) (EN SEE FISC NOTE LF RV See Note)

Version chain

The bill's text revisions, in order — the diff chain from filing to enrollment.

1. SB243 Original (filed) — source
2. SB243 Act (committee substitute) — source
3. SB243 Engrossed (committee substitute) — source
4. Senate Committee Amendment, #1218, R&F, Draft (committee substitute) — source
5. Senate Committee Amendment, #1250, R&F, Adopted (committee substitute) — source
6. SB243 Enrolled (enrolled) — source

Votes

• FINAL PASSAGE (#843) — 95–0 (pass) · lower
• FINAL PASSAGE (#200) — 31–0 (pass) · upper

Sponsors

• Mike Reese — primary (person)

Timeline

The legislative action history — every referral, reading, and vote.

• 2025-06-11 Effective date 6/11/2025.
• 2025-06-11 Signed by the Governor. Becomes Act No. 339. became-law, executive-signature
• 2025-06-09 Sent to the Governor by the Secretary of the Senate. executive-receipt
• 2025-06-08 Signed by the Speaker of the House.
• 2025-06-08 Enrolled. Signed by the President of the Senate. enrolled
• 2025-06-08 Received from the House without amendments. receipt
• 2025-06-03 Read third time by title, roll called on final passage, yeas 95, nays 0. Finally passed, ordered to the Senate. passage
• 2025-06-02 Scheduled for floor debate on 06/03/2025.
• 2025-05-29 Read by title, passed to 3rd reading. reading-3
• 2025-05-28 Reported without Legislative Bureau amendments.
• 2025-05-27 Reported favorably (14-0). Referred to the Legislative Bureau. committee-passage-favorable
• 2025-05-13 Read by title, under the rules, referred to the Committee on Ways and Means. referral-committee
• 2025-05-12 Received in the House from the Senate, read by title, lies over under the rules.
• 2025-05-08 Read by title, passed by a vote of 31 yeas and 0 nays, and sent to the House. Motion to reconsider tabled. passage
• 2025-05-07 Read by title. Committee amendments read and adopted. Ordered engrossed and passed to third reading and final passage.
• 2025-05-06 Reported with amendments. committee-passage-favorable
• 2025-04-28 Read second time by title and referred to the Committee on Revenue and Fiscal Affairs. reading-2, referral-committee
• 2025-04-23 Introduced in the Senate. Read by title and placed on the Calendar for a second reading.

Source

OpenStates / OpenCivicData bulk snapshot 2026-07-01; origin ocd-bill/b249549d-a543-4fd9-9ef9-0ae12e765364. Confidence: reported (aggregated from official Louisiana legislature records).